Search

Displaying results 8441 - 8450 of 10000 in total
  1. Drug

    9,10-Deepithio-9,10-Didehydroacanthifolicin

    go.drugbank.com/drugs/DB02169
    Experimental

    A specific inhibitor of phosphoserine/threonine protein phosphatase 1 and 2a. It is also a potent tumor promoter. (Thromb Res 1992;67(4):345-54 & Cancer Res 1993;53(2):239-41)

  2. Drug

    Recanaclotide

    go.drugbank.com/drugs/DB15417
    Investigational

    Recanaclotide is under investigation in clinical trial NCT01712412 (Phase 2a Study of IW-9179 to Treat Functional Dyspepsia).

  3. Drug

    Lamifiban

    go.drugbank.com/drugs/DB20451
    Experimental

    Lamifiban has a monoisotopic molecular weight of 468.2 Da. … Lamifiban is a small molecule drug. The usage of the INN stem '-fiban' in the name indicates that Lamifiban is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist).

  4. Drug

    Lotrafiban

    go.drugbank.com/drugs/DB20872
    Experimental

    Lotrafiban has a monoisotopic molecular weight of 428.24 Da. … Lotrafiban is a small molecule drug. The usage of the INN stem '-fiban' in the name indicates that Lotrafiban is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist).

  5. Drug

    Tanogitran

    go.drugbank.com/drugs/DB21367
    Investigational

    Tanogitran has a monoisotopic molecular weight of 477.25 Da. … Tanogitran is a small molecule drug.

  6. Drug

    Pixavir marboxil

    go.drugbank.com/drugs/DB21589
    Experimental

    Pixavir marboxil has a monoisotopic molecular weight of 540.12 Da. … Pixavir marboxil is a small molecule drug. The usage of the INN stem '-xavir' in the name indicates that Pixavir marboxil is a influenza CAP-dependent endonuclease inhibitor.

  7. Drug

    Asciminib

    go.drugbank.com/drugs/DB12597
    ApprovedInvestigational

    Asciminib is a tyrosine kinase inhibitor (TKI) used in the treatment of chronic-phase Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). … More specifically, it is an inhibitor of the ABL1 kinase activity of the BCR-ABL1 fusion protein[L38995] which serves as a driver of CML proliferation in most patients with the disease.

  8. Drug

    8-chlorotheophylline

    go.drugbank.com/drugs/DB14132
    Experimental

    8-Chlorotheophylline is a stimulant drug of the xanthine chemical class, with physiological effects similar to caffeine. … Because adenosine causes a decrease in neuronal firing, blockade of the adenosine receptor causes the reverse effect resulting in excitation.

  9. Drug

    Elunonavir

    go.drugbank.com/drugs/DB21518
    Experimental

    Elunonavir is a small molecule drug. The usage of the INN stem '-vir' in the name indicates that Elunonavir is a antiviral. Elunonavir has a monoisotopic molecular weight of 1155.44 Da.

  10. Drug

    Trecadrine

    go.drugbank.com/drugs/DB19785
    Experimental

    Trecadrine is a small molecule drug. The usage of the INN stem '-drine' in the name indicates that Trecadrine is a sympathomimetic. Trecadrine has a monoisotopic molecular weight of 383.22 Da.